Pancytopenia warning added to label of hepatitis C drug boceprevir
Posted on: 13/02/2014 - 21:55
A warning about cases of pancytopenia linked to the use of the oral hepatitis C antiviral drug boceprevir has been added to the drug’s label, the Food and Drug Administration has announced. There...
Field of Interest: Oncology
Type: News Item